A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease - The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial

Pepine, CJ; Handberg, EM; Cooper-Dehoff, RM; Marks, RG; Kowey, P; Messerli, FH; Mancia, G; Cangiano, JL; Garcia-Barreto, D; Keltai, M; Erdine, S; Bristol, HA; Kolb, HR; Bakris, GL; Cohen, JD; Parmley, WW

doi:10.1001/jama.290.21.2805

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease - The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial

Copy For Citation

Pepine C., Handberg E., Cooper-Dehoff R., Marks R., Kowey P., Messerli F., ...More

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, vol.290, no.21, pp.2805-2816, 2003 (SCI-Expanded)

Publication Type: Article / Article
Volume: 290 Issue: 21
Publication Date: 2003
Doi Number: 10.1001/jama.290.21.2805
Journal Name: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.2805-2816
Istanbul University Affiliated: No

Abstract

Context Despite evidence of efficacy of anti hypertensive agents in treating hypertensive patients, safety and efficacy of anti hypertensive agents for coronary artery disease (CAD) have been discerned only from subgroup analyses in large trials.